Health Minister Mandaviya Conducts Review Meeting; Says Sufficient Buffer Stock Of Covid-19 Drugs Available In India

·1-min read

The Union Ministry of Health and Family Welfare has assured that India has sufficient stock of the Covid-19 drugs after Union Minister Mansukh Mandaviya assessed the supply and availability of these medicines on Wednesday.

A strategic buffer stock has been created for about eight drugs, namely: Posaconazole, Enaxopirin, Dexamethasone, Remdesivir, Amphotericin B deoxycholate, Tocilizumab, Methyl Predinisolone and also intravenous Immunoglobulin.

The Health Ministry added that adequate stock of medicines and raw materials have been made available in necessary quantities across the country.

Meanwhile, Union Minister Mandaviya also conducted a review of the prevalent situation of the pandemic in Tamil Nadu, Kerala and Karnataka. He stressed upon taking the appropriate measures to restrict the inter-state spread of the virus.

Moreover, the state health ministers of Karnataka and Tamil Nadu were directed to ramp up the pace of vaccination in the districts that border Kerala, possibly owing to the rapid surge of cases in the southern state.

Senior officials from the Union Health Ministry were a part of this review meeting chaired by Mandaviya, Times of India reports.

Our goal is to create a safe and engaging place for users to connect over interests and passions. In order to improve our community experience, we are temporarily suspending article commenting